DXR
Daxor Corporation [DXR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DXR Stock Summary
Top DXR Correlated Resources
DXR
Top 10 Correlated ETFs
DXR
Top 10 Correlated Stocks
DXR
In the News
DXR Financial details
Company Rating
-
Market Cap
45.23M
Income
5.75M
Revenue
34.31M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
37
Optionable
No
Shortable
Yes
Earnings
25 Mar 2024
P/E
7.8
Forward P/E
-
PEG
7.08
P/S
7.42
P/B
1.39
P/C
-
P/FCF
-60.83
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.41
EPS next Y
-
EPS next Q
-
EPS this Y
-95.23%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
NAN%
Revenue Q/Q
-2164.76%
EPS Q/Q
-201.47%
-
-
-
-
SMA20
6.49%
SMA50
16.75%
SMA100
44.06%
Inst Own
-
Inst Trans
-
ROA
17%
ROE
21%
ROC
0.17%
Gross Margin
100%
Oper. Margin
83%
Profit Margin
82%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.11-13.13
52W High
-10.31%
52W Low
+66.57%
RSI
60.65
Rel Volume
2.37
Avg Volume
2.53K
Volume
6K
Perf Week
9.69%
Perf Month
17.54%
Perf Quarter
39.98%
Perf Half Y
42.54%
-
-
-
-
Beta
-0.435
-
-
Volatility
0.19%, 0.56%
Prev Close
4.95%
Price
11.66
Change
1.3%
Company Profile
- Volume Average 2.53K
- Market Capitalization 45.23M
- Employee 37
- CEO Mr. Michael Richard Feldschuh
- Headquarters Oak Ridge,TN,US
- IPO Date 1983-07-25
-
Website
https://www.daxor.com 
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
